These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 19936746)
1. Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation. Schmidt D; Linke R; Uder M; Kuwert T Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):699-705. PubMed ID: 19936746 [TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid carcinoma: Incremental diagnostic value of Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475 [TBL] [Abstract][Full Text] [Related]
3. Role of [ Xu Q; Liu R; Wang J; Huang Y; Li S; Zhang L; Wang F Nucl Med Biol; 2020; 88-89():34-43. PubMed ID: 32688289 [TBL] [Abstract][Full Text] [Related]
4. Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study. Ilhan H; Mustafa M; Bartenstein P; Kuwert T; Schmidt D Nuklearmedizin; 2016 Dec; 55(6):221-227. PubMed ID: 27588323 [TBL] [Abstract][Full Text] [Related]
5. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884 [TBL] [Abstract][Full Text] [Related]
6. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595 [TBL] [Abstract][Full Text] [Related]
7. Follow-up of differentiated thyroid cancer. Pacini F Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551 [TBL] [Abstract][Full Text] [Related]
8. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation]. Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745 [TBL] [Abstract][Full Text] [Related]
9. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
10. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
11. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer. Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827 [TBL] [Abstract][Full Text] [Related]
12. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225 [TBL] [Abstract][Full Text] [Related]
13. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma. Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600 [TBL] [Abstract][Full Text] [Related]
14. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma. Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466 [TBL] [Abstract][Full Text] [Related]
15. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin? Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer. Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine approaches in the monitoring of thyroid cancer patients. Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A J BUON; 2006; 11(4):511-8. PubMed ID: 17309186 [TBL] [Abstract][Full Text] [Related]
19. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Lind P; Kohlfürst S Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610 [TBL] [Abstract][Full Text] [Related]
20. Lung metastases in patients with differentiated thyroid carcinoma and evaluation of response to radioiodine therapy. Kalender E; Zeki Celen Y; Elboga U; Deniz Demir H; Yilmaz M Rev Esp Med Nucl Imagen Mol; 2012; 31(6):328-31. PubMed ID: 23084016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]